Ong, Janus P <br/><br/>
Oral L-ornithine-L-aspartate improves health-related quality of life in cirrhotic patients with hepatic encephalopathy: an open-label, prospective, multicentre observational study.  [electronic resource] 

 -  Clinical drug investigation  2011 
 - 213-20 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1173-2563 
<br/><br/><label>Standard No.: </label>10.2165/11586700-000000000-00000  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Administration, Oral<br/>Adult<br/>Aged<br/>Dipeptides--adverse effects<br/>Female<br/>Hepatic Encephalopathy--drug therapy<br/>Humans<br/>Liver Cirrhosis--complications<br/>Male<br/>Middle Aged<br/>Prospective Studies<br/>Quality of Life